The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Athira Pharma Inc (NASDAQ: ATHA) was $0.42 for the day, up 4.08% from the previous closing price of $0.4. In other words, the price has increased by $4.08 from its previous closing price. On the day, 0.51 million shares were traded. ATHA stock price reached its highest trading level at $0.459 during the session, while it also had its lowest trading level at $0.3901.
Ratios:
Our analysis of ATHA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.26 and its Current Ratio is at 7.26. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on September 19, 2024, Downgraded its rating to Neutral and sets its target price to $0.50 from $5 previously.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 01 ’25 when CHURCH KEVIN sold 8,526 shares for $0.29 per share. The transaction valued at 2,502 led to the insider holds 168,901 shares of the business.
Litton Mark James sold 25,123 shares of ATHA for $7,374 on Jul 01 ’25. The President and CEO now owns 325,802 shares after completing the transaction at $0.29 per share. On Jul 01 ’25, another insider, San Martin Javier, who serves as the CHIEF MEDICAL OFFICER of the company, sold 10,842 shares for $0.29 each. As a result, the insider received 3,182 and left with 71,665 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATHA now has a Market Capitalization of 17107336 and an Enterprise Value of -23762182.
Stock Price History:
The Beta on a monthly basis for ATHA is 2.99, which has changed by -0.8731928 over the last 52 weeks, in comparison to a change of 0.11844492 over the same period for the S&P500. Over the past 52 weeks, ATHA has reached a high of $3.67, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is 39.46%, while the 200-Day Moving Average is calculated to be -1.79%.
Shares Statistics:
ATHA traded an average of 591.77K shares per day over the past three months and 314550 shares per day over the past ten days. A total of 39.04M shares are outstanding, with a floating share count of 33.48M. Insiders hold about 14.24% of the company’s shares, while institutions hold 45.08% stake in the company. Shares short for ATHA as of 1749772800 were 1484129 with a Short Ratio of 2.51, compared to 1747267200 on 749785. Therefore, it implies a Short% of Shares Outstanding of 1484129 and a Short% of Float of 4.5300003.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
